Vasopressin Market Trends 2021 | Segmentation, Outlook, Industry Report to 2027

The Vasopressin Market size is expected to grow at an annual average of 13% during 2021-2027. Vasopressin is a peptide hormone used to increase blood pressure levels in people with vasoparalytic shock that occurs after heart surgery. Vasopressin is a drug used to treat diabetes insipidus, which is caused by a lack of pituitary hormone in the body. In clinical models of cardiac arrest and related syndromes, vasopressin increases the chances of long-term survival by supplying blood to the heart and brain. In addition to this, vasopressin is indicated for the treatment of gastrointestinal bleeding and ventricular defibrillation. Various trials have shown that infusion of vasopressin in these patients increases the level of systemic vascular resistance to vasoparalytic shock. Vasopressin increases arterial pressure in patients, giving them a better chance of survival.

The following segmentation are covered in this report:

By Application

  • Anti-Diuretic Hormone Deficiency
  • Gastrointestinal Bleeding
  • Vasodilatory Shock
  • Ventricular Tachycardia & Fibrillation

By Type

  • Intravenous Injection
  • Intramuscular Injection
  • Subcutaneous Injection

By End User

  • Hospital
  • Clinics
  • Others

Company Profile

  • Arkema
  • Covestro AG
  • Dow
  • Formosa Plastics Corporation
  • Grasim Industries Limited
  • Hanwha Solutions/Chemical Corporation
  • INOVYN
  • Kemira Oyj
  • Occidental Petroleum Corporation
  • Olin Corporation
  • SABIC
  • Shin-Etsu Chemical Co. Ltd
  • The Sanmar Group
  • Westlake Chemical Corporation

Scope of the report

The research study analyses the Vasopressin Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent developments

  • Market overview and growth analysis
  • Import and export overview
  • Volume analysis
  • Current market trends and future outlook
  • Market opportunistic and attractive investment segment

Geographic coverage

  • North america market size and/or volume
  • Latin america market size and/or volume
  • Europe market size and/or volume
  • Asia-pacific market size and/or volume
  • Rest of the world market size and/or volume

Key Questions Answered by Vasopressin Market Report

  • What was the Vasopressin Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027)
  • What will be the CAGR of Market during the forecast period (2021-2027)?
  • Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
  • Which manufacturer/vendor/players in the Vasopressin Market was the market leader in 2020?
  • Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.

The report will be delivered within 48-72 hours after payment confirmation